aTyr Pharma Inc. | Key People and Executives
Sanjay Shukla
President, Chief Executive Officer & Director
Timothy P. Coughlin
Independent Director
Jeffrey S. Hatfield
Independent Director
John D. Mendlein
Independent Director
Amir H. Nashat
Independent Director
Paul R. Schimmel
Independent Director
Jim C. Blair
Independent Director
Sanjay S. Shukla
President, Chief Executive Officer & Director
Jill M. Broadfoot
Chief Financial & Accounting Officer
David John King
Chief Scientific Officer
Ashraf Amanullah
Senior VP-Biologics Development & Manufacturing
Andrew B. Cubitt
Vice President-External Scientific Alliances
Mark Johnson
Senior Director-Investor Relations
Grove Matsuoka
Chief of Staff
Nancy Denyes Krueger
Secretary & Vice President-Legal Affairs
Timothy P. Coughlin
Independent Director
Jeffrey S. Hatfield
Independent Director
John D. Mendlein
Independent Director
Amir H. Nashat
Independent Director
Paul R. Schimmel
Independent Director
Jim C. Blair
Independent Director
| Address |
3545 John Hopkins Court
San Diego California 92121
United States
|
|
Employees
|
- |
| Website |
http://www.atyrpharma.com |
| Updated |
07/08/2019 |
| aTyr Pharma, Inc. develops protein therapeutics and novel class of biologic drugs. It plans to build a pipeline of innovative therapeutic products based on Physiocrine biology. The company has established a dominant intellectual property estate to protect the core therapeutics as well as associated diagnostics. |
